Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates Dr. Srinivas Kudva12 Nov 2025 12:00 PM ISTIndia faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions that frequently overlap...
Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin Dr. Prakash Kumar11 Nov 2025 11:30 AM ISTCardiovascular diseases (CVDs) are the leading cause of non-communicable disease (NCD) deaths in India, accounting for nearly 48% of all NCD...
India's Unique CV Risk Profile: How to Decode the Role of Aspirin? Dr. Ajay U. Mahajan7 Oct 2025 11:47 AM ISTCardiovascular disease remains one of the dominant non-communicable causes of death in India, contributing substantially to premature morbidity and...
Identifying Aspirin Candidates for Primary Prevention: Focus on Men Aged 40- 50 with Metabolic Syndrome and Cardiometabolic Risk Lalhmangaihkimi29 Sept 2025 12:15 PM ISTUnique CV Risk in India- Epidemiological BackdropCardiovascular diseases (CVDs) remain the leading cause of death in India, with a WHO-reported...
Young, Diabetic, and at High CV Risk: Is It Time for Early Aspirin? Dr. Amit V. Joshi18 Aug 2025 11:47 AM ISTYoung, Diabetic, and at High CV Risk: A Case for Early CV Prevention with Aspirin in the High-Risk Young
Management of Hypertension: How Innovative Packaging Can Improve Patient Outcomes? Dr. Garima Soni29 July 2025 12:00 PM ISTBurden of Hypertension in India and The Need for Educational Interventions With an estimated 315 million people affected by hypertension in...
Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India Dr. Bhumika Maikhuri18 July 2025 10:20 AM ISTDespite advancements in healthcare, pneumococcal disease continues to pose a serious and growing threat to adults in India, particularly those over...
Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings Dr. Rahul R. Patil7 July 2025 11:42 AM ISTIntroduction: Stroke Burden and Aspirin's RoleThe stroke burden in India is substantial and growing, with an incidence of 119-145 per 100,000 annually...
Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension, Dyslipidemia, and Familial ASCVD Risk Pradeep Eswarappa Haranahalli1 July 2025 11:03 AM ISTPremature ASCVD: Why Age 40-50 Males Need Closer Attention? Premature ASCVD is rising sharply in Indian men aged 40-50, demanding earlier...
Beyond BMI: Why Pioglitazone Deserves a Place in Managing 'Thin-Fat' Type 2 Diabetes in India Dr. Kaushik Pandit26 Jun 2025 11:03 AM ISTThin-Fat Paradox in Indian T2DM - A Distinct Metabolic Challenge: In the Indian population, the 'thin-fat' phenotype-normal BMI with excess visceral...
How to Improve Adherence in Hypertensive Patients? Bridging the Gap with CONNECT Tool Dr. K.R.K.S Raju25 Jun 2025 11:30 AM ISTThe Hidden Crisis: Uncontrolled Hypertension in IndiaHypertension significantly contributes to a wide spectrum of cardiovascular and metabolic...
